Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Mersana Therapeutics Inc. (MRSN)

7.8   0.15 (1.96%) 02-14 16:00
Open: 7.68 Pre. Close: 7.65
High: 8.11 Low: 7.4518
Volume: 285,200 Market Cap: 353M
Mersana Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.119 - 8.151 8.151 - 8.179
Low: 7.366 - 7.404 7.404 - 7.436
Close: 7.733 - 7.796 7.796 - 7.85

Technical analysis

as of: 2020-02-14 4:30:51 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 10.43     One year: 12.18
Support: Support1: 6.56    Support2: 5.09
Resistance: Resistance1: 8.93    Resistance2: 10.43
Pivot: 7.36
Moving Average: MA(5): 7.79     MA(20): 7.47
MA(100): 4.07     MA(250): 4.13
MACD: MACD(12,26): 0.47     Signal(9): 0.51
Stochastic oscillator: %K(14,3): 76.42     %D(3): 74.76
RSI: RSI(14): 59.70
52-week: High: 8.93  Low: 1.32  Change(%): 16.2
Average Vol(K): 3-Month: 40433  10-Days: 32865

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
MRSN has closed below upper band by 24.0%. Bollinger Bands are 0.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-11-14
Mersana Therapeutics (NASDAQ:MRSN) Sees Large Volume Increase
Shares of Mersana Therapeutics Inc (NASDAQ:MRSN) saw unusually-strong trading volume on Wednesday . Approximately 950,700 shares traded hands during trading, an increase of 292% from the previous session’s volume of 242,340 shares.The stock last traded at $2.78 and had previously closed at $2.30. Several analysts recently issued reports on MRSN shares. HC Wainwright reaffirmed a […]

2019-11-11
$500,000.00 in Sales Expected for Mersana Therapeutics Inc (NASDAQ:MRSN) This Quarter
Wall Street brokerages expect Mersana Therapeutics Inc (NASDAQ:MRSN) to announce $500,000.00 in sales for the current quarter, according to Zacks. Three analysts have issued estimates for Mersana Therapeutics’ earnings. The lowest sales estimate is $250,000.00 and the highest is $1.00 million. Mersana Therapeutics posted sales of $1.19 million in the same quarter last year, which […]

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 45.31
Shares Float (M) 24.54
% Held by Insiders
% Held by Institutions
Shares Short (K) 826
Shares Short P. Month (K)

Stock Financials

EPS -0.920
Book Value (p.s.) 1.940
PEG Ratio
Profit Margin -79.49
Operating Margin -84.08
Return on Assets (ttm) -21.0
Return on Equity (ttm) -56.0
Qtrly Rev. Growth -60.8
Gross Profit (p.s.) -1.089
Sales Per Share
EBITDA (p.s.) -0.774
Qtrly Earnings Growth
Operating Cash Flow (M) -71.07
Levered Free Cash Flow (M) -27.82

Stock Valuations

P/E -8.48
P/E Growth Ratio 0.02
P/BV 4.02
P/S 6.72
P/CF -4.97

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.